Active Pharmaceutical Ingredient

India is currently the largest producer of generic medicines with a share of 20% of total global production globally, catering to over 60% of world's demand

The USFDA placed Laxachem Organics on import alert 99-32 that allows detention without physical examination of products from firms refusing FDA foreign establishment inspection

Dr. Reddy's Laboratories is creating a branded generics platform in North America and expanding biologics play in Russia and emerging markets

The US drug monitor announced new rates for annual facility fees, with rates for foreign facilities up by 12-15%

Ipca gets US FDA nod for Propranolol